Robert Snijder

Capsaicin 8% Patch in Painful Diabetic Peripheral Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Study

David M. Simpson, Jessica Robinson‐Papp, Joanna Van et al. · Journal of Pain · 2016 · 170 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Capsaicin 8% patch repeat treatment plus standard of care (SOC) versus SOC alone in painful diabetic peripheral neuropathy: a randomised, 52-week, open-label, safety study

Aaron I. Vinik, Serge Perrot, Etta J. Vinik et al. · BMC Neurology · 2016 · 105 citations · Full text

Pharmacy, Pharmacotherapy, Diabetic Foot Care +16

A proof‐of‐concept study: Mirabegron, a new therapy for overactive bladder

Christopher R. Chapple, G. Amarenco, López Aramburu et al. · Neurourology and Urodynamics · 2013 · 96 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Afatinib plus gemcitabine versus gemcitabine alone as first-line treatment of metastatic pancreatic cancer: The randomised, open-label phase II ACCEPT study of the Arbeitsgemeinschaft Internistische Onkologie with an integrated analysis of the ‘burden of therapy’ method

Michael Haas, Dirk Waldschmidt, Michael Ståhl et al. · European Journal of Cancer · 2021 · 33 citations

Medicine, Oncology, Pharmacology +15

Incidence of urinary retention during treatment with single tablet combinations of solifenacin+tamsulosin OCAS™ for up to 1 year in adult men with both storage and voiding LUTS: A subanalysis of the NEPTUNE/NEPTUNE II randomized controlled studies

Marcus J. Drake, Matthias Oelke, Robert Snijder et al. · PLoS ONE · 2017 · 25 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +12